Lipaglyn Tablet

Description

Lipaglyn Tablet is a prescription medicine used to manage diabetic dyslipidemia and hypertriglyceridemia, especially in patients with type 2 diabetes. It contains Saroglitazar, a dual PPAR (Peroxisome Proliferator-Activated Receptor) agonist, which helps lower blood triglycerides, improve cholesterol levels, and enhance insulin sensitivity.

How it Works:

• Saroglitazar activates PPAR-α and PPAR-γ receptors, helping reduce lipid levels in the blood while improving glucose metabolism.

• It addresses both blood sugar control and lipid abnormalities, reducing cardiovascular risk in diabetic patients.

Dosage:
Take Lipaglyn Tablet as prescribed by your doctor, usually once daily. It is recommended to take it after food. Do not exceed the prescribed dose.

Side Effects:

• Indigestion or nausea

• Headache

• Swelling in hands or feet

• Fatigue

• Rarely, muscle pain or liver enzyme changes

Precautions:

• Not recommended for patients with severe liver or kidney disease.

• Regular monitoring of blood sugar, liver, and kidney function is advised.

• Pregnant or breastfeeding women should avoid use unless prescribed by a doctor.

• Inform your doctor about other medications to prevent interactions.

Storage:
Store in a cool, dry place below 25°C, away from direct sunlight and moisture. Keep out of reach of children.